fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and
.: "fremanezumab for the preventive treatment of chronic migraine."
. a senior northern ireland civil servant has apologised after hundreds of neurology patients were recalled for further testing.
.
.